Using a Fan With Aromatherapy in Breathlessness Patients in Terminal Illness

Study Overview
=================
Brief Summary
-----------------
Difficulty breathing is a very devastating symptom, often seen in terminal patients. Accompanied by physical, psychological, emotional, and social limitations, Not to mention the ambiguity in the occurrence of dyspnea symptoms and the difficulty in obtaining satisfactory quality of symptom care. The purpose of this study is to confirm the use of non-drug interventions in clinical situations, such as fans and aromatherapy to alleviate the complications of end-stage patients. The effectiveness of the symptoms of dyspnea.

Detailed Description
-----------------
Difficulty breathing is a very devastating symptom, often seen in terminal patients. Accompanied by physical, psychological, emotional, and social limitations, Not to mention the ambiguity in the occurrence of dyspnea symptoms and the difficulty in obtaining satisfactory quality of symptom care. The purpose of this study is to confirm the use of non-drug interventions in clinical situations, such as fans and aromatherapy to alleviate the complications of end-stage patients. The effectiveness of the symptoms of dyspnea. Inclusion criteria Over 20 years old. It is determined by the physician to meet the final diagnosis conditions. Symptoms of dyspnea. The daily physical status of patients is assessed using the East Coast Cancer Clinical Research Cooperative Organization Assessment Scale (Eastern Cooperative Oncology Group, ECOG) ≧ 2 points. Able to communicate in Mandarin or Taiwanese or written conversation. Unconscious disorder. After explaining and explaining, agree to participate in this research and sign the consent form. Exclusion criteria Receive treatment for facial trigeminal nerve damage. Abnormal sense of smell.

Official Title
-----------------
The Effect of Using a Fan With Aromatherapy in Breathlessness Patient in Terminally Illness: a Randomized Control Trial

Conditions
-----------------
Breathlessness, Aromatherapy, Fans, Terminal Illness

Intervention / Treatment
-----------------
* Behavioral: Blow a fan to the face combine aromatherapy
* Behavioral: Blow a fan to the face
* Behavioral: Blow a fan to the feet


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Over 20 years old. It is determined by the physician to meet the final diagnosis conditions. Symptoms of dyspnea. The status of patients is assessed using the East Coast Cancer Clinical Research Cooperative Organization Assessment Scale (ECOG) ≧ 2 points. Able to communicate in Mandarin or Taiwanese or written conversation. Conscience clear. After explaining and explaining, agree to participate in this research and sign the consent form. Exclusion Criteria: Receive treatment for facial trigeminal nerve damage. Abnormal sense of smell.

Ages Eligible for Study
-----------------
Minimum Age: 20 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Design Details

Primary Purpose: Supportive Care
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Blow a fan to the face combine aromatherapy<br> | Behavioral: Blow a fan to the face combine aromatherapy<br>* Blow a fan with aromatherapy to the face<br>|
| Experimental: Blow a fan to the face<br> | Behavioral: Blow a fan to the face<br>* Blow a fan to the face<br>|
| Placebo Comparator: Blow a fan to the feet<br> | Behavioral: Blow a fan to the feet<br>* Blow a fan to the feet<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Chinese version of the Respiratory Distress Observation Scale，C-RDOS | RDOS is an eight-item ordinal scale designed to measure the presence and intensity of respiratory distress in adults. High score means high respiratory distress. | The score change up to three days. | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Patient Health Questionnaire (PHQ-9) | The PHQ-9 is the depression module, which scores each of the nine DSM-IV criteria as 0 (not at all) to 3 (nearly every day). It has been validated for use in primary care.[2] It is not a screening tool for depression but it is used to monitor the severity of depression and response to treatment. high score mean higher emotion distress. | The score change up to three days. | 
| Chinese version of the Edmonton Symptom Assessment System，C-ESAS | The ESAS includes 11 symptoms: pain, tiredness, nausea, depression, anxiety, drowsiness, appetite, sleep, well-being, shortness of breath, and other. It uses a 0-10 numerical scale: 0 shows the absence of a symptom, and 10 shows the worst experience of the symptom. | The score change up to three days. | 
| Smart bracelet_Heart rate variability (HRV) | HRV is the physiological phenomenon of the variation in the time interval between consecutive heartbeats in milliseconds. A normal, healthy heart does not tick evenly like a metronome, but instead, when looking at the milliseconds between heartbeats, there is constant variation. | Continue wear bracelet five days to record HRV data. |